APA (7th ed.) Citation

Chen, J., Lai, W., Lin, R., Juo, S. H., & Liang, C. (2024). Safety and Tolerability of Anti–microRNA-328 Ophthalmic Solution, SHJ002, in Pediatric Subjects: First-in-Human Clinical Study. Clinical therapeutics, 46(10), 768-772. https://doi.org/10.1016/j.clinthera.2024.08.015

Chicago Style (17th ed.) Citation

Chen, Jiunn-Liang, Wei-Yu Lai, Reuy-Tay Lin, Suh-Hang H. Juo, and Chung-Ling Liang. "Safety and Tolerability of Anti–microRNA-328 Ophthalmic Solution, SHJ002, in Pediatric Subjects: First-in-Human Clinical Study." Clinical Therapeutics 46, no. 10 (2024): 768-772. https://doi.org/10.1016/j.clinthera.2024.08.015.

MLA (9th ed.) Citation

Chen, Jiunn-Liang, et al. "Safety and Tolerability of Anti–microRNA-328 Ophthalmic Solution, SHJ002, in Pediatric Subjects: First-in-Human Clinical Study." Clinical Therapeutics, vol. 46, no. 10, 2024, pp. 768-772, https://doi.org/10.1016/j.clinthera.2024.08.015.